Elanco Animal Health Inc (ELAN) stock
ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$25.85−0.56 (-2.12%)
Close on Nov 17, 2026Market cap $12.92BP/E –Yield –
Elanco Animal Health EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Elanco Animal Health's EV/EBITDA was 31.5× on Nov 11, 2026, against 23.1× a year earlier. Over the last 5 years it ranged from 7.3× to 194.9×, with a median of 27.7×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 31.5× | +9.0 |
| 2025 | Dec 31, 2025 | 22.6× | +15.2 |
| 2024 | Dec 31, 2024 | 7.4× | −4.6 |
| 2023 | Oct 31, 2023 | 11.9× | −1.8 |
| 2022 | Dec 30, 2022 | 13.7× | −67.6 |
| 2021 | Dec 31, 2021 | 81.4× | −75.4 |
| 2020 | Dec 31, 2020 | 156.7× | +128.8 |
| 2019 | Dec 31, 2019 | 28.0× | −21.2 |
| 2018 | Dec 31, 2018 | 49.1× | – |
See a number that looks wrong?